ABEO Abeona Therapeutics

Abeona Therapeutics, Inc. is a clinical stage biopharmaceutical company, which engages in the development of gene therapy for severe and life threatening rare diseases. It programs include EB-101 (gene-corrected skin grafts) for recessive dystrophic epidermolysis bullosa (RDEB); ABO-102 (AAV-SGSH), an adeno-associated virus (AAV) based gene therapy for Sanfilippo syndrome type A (MPS IIIA) and ABO-101 (AAV NAGLU), an AAV based gene therapy for Sanfilippo syndrome type B (MPS IIIB). The company was founded in 1974 and is headquartered in New York, NY.

Company profile

Jeffrey Davis
Fiscal year end
Former names
IRS number

ABEO stock data


Investment data

Data from SEC filings
Securities sold
Number of investors


24 Mar 21
18 Apr 21
31 Dec 21
Quarter (USD)
Dec 20 Sep 20 Jun 20 Mar 20
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS
Annual (USD)
Dec 20 Dec 19 Dec 18 Dec 17
Cost of revenue
Operating income
Operating margin
Net income
Net profit margin
Cash on hand
Change in cash
Diluted EPS

Financial data from company earnings reports.

Cash burn rate (estimated) Burn method: Change in cash Burn method: Operating income/loss Burn method: FCF (opex + capex)
Last Q Avg 4Q Last Q Avg 4Q Last Q Avg 4Q
Cash on hand (at last report) 13.57M 13.57M 13.57M 13.57M 13.57M 13.57M
Cash burn (monthly) (positive/no burn) 9.73M 4.83M 6.79M 536.67K 2.92M
Cash used (since last report) n/a 35.22M 17.47M 24.55M 1.94M 10.56M
Cash remaining n/a -21.65M -3.9M -10.98M 11.63M 3.01M
Runway (months of cash) n/a -2.2 -0.8 -1.6 21.7 1.0

Beta Read what these cash burn values mean

Date Owner Security Transaction Code Indirect 10b5-1 $Price #Shares $Value #Remaining
5 Apr 21 Carr Edward Common stock Sell Dispose S No Yes 1.7956 35,000 62.85K 191,291
1 Apr 21 Carr Edward Common stock Sell Dispose S No Yes 1.8521 20,445 37.87K 226,291
31 Mar 21 Michael Amoroso Common stock Sell Dispose S No Yes 1.8701 45,409 84.92K 650,046
19 Mar 21 Michael Amoroso Common stock Grant Aquire A No No 0 250,000 0 695,455
19 Mar 21 Michael Amoroso Stock Option Common Stock Grant Aquire A No No 2.18 500,000 1.09M 500,000

Data for the last complete 13F reporting period. To see the most recent changes to ownership, click the ownership history button above.

13F holders
Current Prev Q Change
Total holders 0 0
Opened positions 0 0
Closed positions 0 0
Increased positions 0 0
Reduced positions 0 0
13F shares
Current Prev Q Change
Total value 0 0
Total shares 0 0
Total puts 0 0
Total calls 0 0
Total put/call ratio
Largest owners
Shares Value Change
Largest transactions
Shares Bought/sold Change
Content analysis
H.S. sophomore Avg
New words: AAA, absent, accommodate, adulterated, Aid, Alto, ambit, Amoroso, ANTIDILUTIVE, apparent, attest, bill, bioreactor, black, box, boxed, branch, bronchial, brought, Bruckner, capita, cDNA, chance, clarity, communicable, Condensed, congregating, controversy, corneal, counterfeit, credible, CRL, custody, danger, deadline, Dear, declaratory, Dermatology, detention, diarrhea, die, disagree, disbursed, disfiguring, disregard, donor, DQSA, draft, drop, EC, economy, embedded, embezzling, episode, ester, faith, fault, filer, filtered, fluorescent, forgiven, fovea, fused, fusing, gather, gave, GDP, George, Germany, gradually, green, grown, harvested, helper, heterogeneity, HHS, Hirsch, home, Hull, impractical, improperly, inaccurate, inactive, inconclusive, ineligible, inevitable, ingredient, Inline, intentionally, Interactive, interface, intermittent, intervene, Journal, justly, lattice, laying, lender, likewise, linear, loan, lowest, Mann, master, mechanistically, media, Michael, Migausky, MMA, moderate, mortgage, mutual, nasal, navigating, necessitate, neurodevelopmental, nil, noncompliance, notwithstanding, novo, nurse, obstructing, OECD, offense, openly, ophthalmic, Orphanet, outer, outweigh, owe, Page, Palo, pandemic, passed, pause, paused, Paycheck, PBM, PDMA, penetrated, pharmacy, photoreceptor, pigmented, plasmid, plausible, PMA, Poor, postpone, postponed, PPP, predicated, preempted, premarket, prioritize, prolonged, prudent, qualification, quantity, quarantine, qui, reassessing, redirected, redundancy, regain, reinstituting, Relief, remote, renegotiate, repay, repricing, resumed, resuming, reveal, revoked, route, running, salt, SBA, searchable, SGSH, shareholder, Shawn, shortage, shorter, sixty, starter, stealing, sum, surface, survey, tam, Taysha, temporarily, thought, timepoint, Tomasello, tracing, training, transient, trick, triple, true, truth, turnover, unanimously, unapproved, unexercised, unfit, unforeseen, unforgiven, untrue, unvested, variant, verify, veterinary, VIITALTM, virtual, vomiting, White, workforce
Removed: administering, Alvino, AMAG, amortizing, behavior, budget, buildup, burn, called, Chairman, collateral, collectible, commitment, correct, cumulative, detect, devoted, digest, Donald, doubtful, EBMRF, EBRP, eventual, fatty, Finland, graph, historic, HS, index, inflation, intrathecal, July, Junior, Leland, lesser, lysosome, MACM, Mark, match, mid, Miller, month, MPSIIIA, MuGard, NCL, NDA, Newfoundland, Norgine, northern, Obama, onset, originally, placement, poorly, President, prohibited, realizable, recalculated, recapitulate, recycle, Reorganization, Southern, speech, suggesting, Sweden, symptomatic, tagged, tenant, text, Timothy, Trump, unamortized, unqualified, view, week